Patients suffering from chronic limb-threatening ischemia (CLTI) may have an alternative to amputation, according to a study co-led by University Hospitals Harrington Heart & Vascular Institute.
New research published in the Journal of the American College of Cardiology shows the use of drug-coated balloons is an optimal approach compared to bare metal stents in treating femoropopliteal lesions.